Saima Zafar

Dr. Saima Zafar

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2016 in Nature Protocols
Verified
Journal Article
Closed access
MSMatthias Schmitz
Matthias Schmitz
MCMaria Cramm
Maria Cramm
Franc LlorensFranc Llorens
Franc Llorens
DMDominik Müller-Cramm
Dominik Müller-Cramm
SCSteven Collins
Steven Collins
IZInga Zerr
Inga Zerr

25 February 2019 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
NCNiccolò Candelise
Niccolò Candelise
MSMatthias Schmitz
Matthias Schmitz
Franc LlorensFranc Llorens
Franc Llorens
AVAnna Villar‐Piqué
Anna Villar‐Piqué
MCMaria Cramm
Maria Cramm
Inga ZerrInga Zerr
Inga Zerr

9 May 2014 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
MCMaria Cramm
Maria Cramm
MSMatthias Schmitz
Matthias Schmitz
AKAndré Karch
André Karch
SZSaima Zafar
Saima Zafar
DVDaniela Varges
Daniela Varges
IZInga Zerr
Inga Zerr
The development of in vitro amplification systems allows detecting femtomolar amounts of prion protein scrapie (PrPSc) in human cerebrospinal fluid (CSF). We performed a CSF study to determine the effects of prion disease type, codon 129 genotype, PrPSc type, and other disease-related factors on the real-time quaking-induced conversion (RT-QuIC) response. We analyzed times to 10,000 relative fluorescence units, areas under the curve and the signal maximum of RT-QuIC response as seeding parameters of interest. Interestingly, type of prion disease (sporadic vs. genetic) and the PRNP mutation (E200K vs. V210I and FFI), codon 129 genotype, and PrPSc type affected RT-QuIC response. In genetic forms, type of mutation showed the strongest effect on the observed outcome variables. In sporadic CJD, MM1 patients displayed a higher RT-QuIC signal maximum compared to MV1 and VV1. Age and gender were not associated with RT-QuIC signal, but patients with a short disease course showed a higher seeding efficiency of the RT-QuIC response. This study demonstrated that PrPSc characteristics in the CSF of human prion disease patients are associated with disease subtypes and rate of decline as defined by disease duration.

1 January 2014 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JDJean-Yves Douet
Jean-Yves Douet
SZSaima Zafar
Saima Zafar
APArmand Perret-Liaudet
Armand Perret-Liaudet
CLCaroline Lacroux
Caroline Lacroux
SLSéverine Lugan
Séverine Lugan
OAOlivier Andreoletti
Olivier Andreoletti
We report the presence of infectivity in erythrocytes, leukocytes, and plasma of 1 person with variant Creutzfeldt-Jakob disease and in the plasma of 2 in 4 persons whose tests were positive for sporadic Creutzfeldt-Jakob disease. The measured infectivity levels were comparable to those reported in various animals with transmissible spongiform encephalopathies.

23 June 2020 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
NYNeelam Younas
Neelam Younas
SZSaima Zafar
Saima Zafar
MSMohsin Shafiq
Mohsin Shafiq
ANAneeqa Noor
Aneeqa Noor
ASAnna Siegert
Anna Siegert
Inga ZerrInga Zerr
Inga Zerr
Dysfunctional RNA-binding proteins (RBPs) have been implicated in several neurodegenerative disorders. Recently, this paradigm of RBPs has been extended to pathophysiology of Alzheimer’s disease (AD). Here, we identified disease subtype specific variations in the RNA-binding proteome (RBPome) of sporadic AD (spAD), rapidly progressive AD (rpAD), and sporadic Creutzfeldt Jakob disease (sCJD), as well as control cases using RNA pull-down assay in combination with proteomics. We show that one of these identified proteins, splicing factor proline and glutamine rich (SFPQ), is downregulated in the post-mortem brains of rapidly progressive AD patients, sCJD patients and 3xTg mice brain at terminal stage of the disease. In contrast, the expression of SFPQ was elevated at early stage of the disease in the 3xTg mice, and in vitro after oxidative stress stimuli. Strikingly, in rpAD patients’ brains SFPQ showed a significant dislocation from the nucleus and cytoplasmic colocalization with TIA-1. Furthermore, in rpAD brain lesions, SFPQ and p-tau showed extranuclear colocalization. Of note, association between SFPQ and tau-oligomers in rpAD brains suggests a possible role of SFPQ in oligomerization and subsequent misfolding of tau protein. In line with the findings from the human brain, our in vitro study showed that SFPQ is recruited into TIA-1-positive stress granules (SGs) after oxidative stress induction, and colocalizes with tau/p-tau in these granules, providing a possible mechanism of SFPQ dislocation through pathological SGs. Furthermore, the expression of human tau in vitro induced significant downregulation of SFPQ, suggesting a causal role of tau in the downregulation of SFPQ. The findings from the current study indicate that the dysregulation and dislocation of SFPQ, the subsequent DNA-related anomalies and aberrant dynamics of SGs in association with pathological tau represents a critical pathway which contributes to rapid progression of AD.

16 September 2020 in The Lancet Neurology
Verified
Journal Article
Closed access
EJEmma Jones
Emma Jones
HHHolger Hummerich
Holger Hummerich
EVEmmanuelle Viré
Emmanuelle Viré
JUJames Uphill
James Uphill
ADAthanasios Dimitriadis
Athanasios Dimitriadis
SMSimon Mead
Simon Mead